ammonium hydroxide and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

ammonium hydroxide has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eagles, CJ; Kendall, MJ1

Trials

1 trial(s) available for ammonium hydroxide and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

ArticleYear
The effects of combined treatment with beta 1-selective receptor antagonists and lipid-lowering drugs on fat metabolism and measures of fatigue during moderate intensity exercise: a placebo-controlled study in healthy subjects.
    British journal of clinical pharmacology, 1997, Volume: 43, Issue:3

    Topics: Adrenergic beta-Antagonists; Adult; Ammonia; Analysis of Variance; Anticholesteremic Agents; Atenolol; Bezafibrate; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Energy Metabolism; Exercise; Fatigue; Fatty Acids, Monounsaturated; Fatty Acids, Nonesterified; Female; Fluvastatin; Heart Rate; Humans; Hypolipidemic Agents; Indoles; Lactic Acid; Lipids; Male; Oxygen Consumption; Triglycerides

1997